Lupin Ltd
NSE: LUPIN BSE: 500257
₹2185.90
(2.65)%
Tue, 03 Feb 2026, 02:31 pm
Market Cap972.34B
PE Ratio23.14
Dividend0.56
Health Technology
Pharmaceuticals: Other
24.5Klupin ltd History
1983
- Lupin Chemicals Ltd incorporated as Private Ltd company.
1991
- Lupin Chemicals Ltd converts to Public Ltd company.
2002
- Lupin introduces AkuriT for tuberculosis treatment.
- CRISIL upgrades Lupin NCD rating from D to BB+.
- Lupin enhances capacity at Aurangabad and Manideep plants.
2003
- Lupin commissions Mandideep facility for Lisinopril.
- Lupin announces VRS for employees.
- Lupin divests 12.55% equity to CVC International.
- Lupin closes South Africa operations and sets up HK and US subsidiaries.
- Lupin receives US FDA approval for cefuroxime axetil tablets.
- Dr. Kamal K. Sharma appointed Additional Director.
- Lupin receives US FDA approval for cefotaxime sterile vials and generic Claforan.
- Lupin receives US FDA approval for Ceftriaxone sterile vials.
- Lupin plans NYSE listing.
- Lupin sets up herbal product division.
- Lupin submits INDA for psoriasis.
2004
- Lupin launches Ezedoc for cholesterol management.
- Lupin appoints Vinod Dhawan as President Business Development.
- Lupin delists shares from Ahmedabad, Delhi, Jaipur, and Calcutta exchanges.
- Lupin enters agreement with Baxter for ceftriaxone in US.
- Lupin launches Lupin Herbal division with nine products.
- Lupin Pharmaceuticals agrees with Allergan for Zymar promotion.
- Lupin launches Suprax cefixime Oral Suspension in US.
- Lupin enters co-marketing with Ind Swift for Nitazoxanide.
2005
- Lupin launches Ceftriaxone vials in the US.
- Lupin enters cooperation agreement with Kyowa for Japan.
- Lupin receives US FDA approval for Cephalexin Oral Suspension.
- Lupin agrees with GSK Philippines for FDCs.
- Lupin receives DCGI approval for Phase II trials of LLL-3348 Desoris.
2006
- Lupin partners with ItalFarmaco to launch Lupenox in India.
- Lupin receives DCGI approval for Phase II psoriasis NCE trials.
- Lupin and Aspen Pharmacare sign MoU for JV.
- Lupin signs MoU to acquire 51% of Artifex Finance CVA and Dafra Pharma.
- Lupin issues 1:1 bonus shares.
2007
- Lupin receives US FDA approval for Trandolapril.
- Lupin inducts PricewaterhouseCoopers for SAP implementation.
- Lupin reduces debt by Rs 20 crore.
- Lupin receives US FDA approval for Simvastatin Tablets.
- Lupin receives MHRA approval for Lisinopril in UK.
- Lupin receives Euro 20 million from Servier for Perindopril patents.
- Lupin receives DCGI approval for Phase IIb/III psoriasis NCE trials.
- DST partners with Lupin for migraine and psoriasis projects.
- Lupin receives Best New Manufacturer award from AmerisourceBergen.
2008
- Lupin appoints R.V. Satam as Secretary and Compliance Officer.
- Lupin enters agreement for Suprax 400 mg tablets.
- Lupin launches Suprax 400 mg Tablets in the US.
- Kyowa receives ten product approvals in Japan.
2009
- Lupin receives US FDA approval for Levetiracetam Tablets.
- Lupin partners with institutes for PhD program.
- Lupin forms equity partnership with Multicare Pharmaceuticals Philippines.
- Lupin acquires worldwide rights for AllerNaze NDA.
2010
- Lupin launches Ilyalgan sodium hyaluronate in India.
- Lupin receives US FDA approval for Imipramine Pamoate capsules.
- Lupin splits share face value from Rs 10 to Rs 2.
2011
- Lupin acquires worldwide rights for Goanna brand.
- Lupin and Medicis enter joint development agreement.
- Lupin acquires I'rom Pharmaceuticals via Japanese subsidiary.
2012
- Lupin receives tentative US FDA approval for generic Glumetza ER Tablets.
- Lupin settles Glumetza patent litigation with Santarus and Depomed.
- Lupin launches generic Geodon Capsules.
- Lupin launches generic Seroquel Tablets.
2013
- Lupin inaugurates new plant at Nagpur.
- Lupin receives Mahindra Samridhhi award for beekeeping and honey production.
- Lupin receives NABARD BEST NGO award for MSGD Alwar.
2014
- Lupin acquires Laboratorios Grin in Mexico and Nanomi B.V.
- Lupin ranked top 10 resilient companies by Economic Times.
- Lupin wins Dun & Bradstreet top Indian pharma award.
- Lupin named great place to work.
- Lupin wins ASTD award for employee learning.
- Lupin receives US FDA approval for generic Actos Tablets.
- Lupin receives US FDA approval for generic Celebrex Capsules.
2015
- Lupin launches generic Diovan Tablets.
- Lupin receives US FDA approval for generic Vancocin Capsules.
- Lupin and Celon announce agreement for generic Advair Diskus.
- Lupin and Rotary partner against tuberculosis in Mumbai.
- Lupin launches generic hypertension drug in the US.
- Lupin receives UBM India Pharma Awards.
- Lupin receives CNBC India Risk Management Awards.
- Lupin acquires Biocom in Russia.
2016
- Lupin launches generic Ortho Tri-Cyclen Lo Tablets in the US.
- Lupin receives US FDA approval for generic Generess tablets.
- Lupin launches generic Glumetza HCI ER Tablets in the US.
- Lupin completes acquisition of GAVIS.
- Lupin launches generic Intermezzo Sublingual Tablets in the US.
- Lupin launches generic Femhrt Tablets in the US.
- Lupin shifts registered office in Mumbai.
- Lupin receives EIR from US FDA for Goa facility.
- Lupin launches ISOFER and JILAZO injectable iron formulations in India.
2017
- Lupin launches generic MS Contin ER Tablets in the US.
- Lupin launches generic Ortho-Cyclen 28 Tablets in the US.
- Lupin launches generic Temovate Clobetasol Propionate Scalp Application in the US.
- Lupin launches generic Pristiq Tablets in the US.
- Lupin launches generic Paxil CR tablets in the US.
- Lupin receives approval for Roxicodone tablets.
- Lupin receives US FDA approval for generic Crestor tablets.
2018
- Lupin launches generic Ancobon capsules in the US.
- Lupin receives approval for Tamiflu capsules.
- Lupin receives US FDA approval for skin conditions cream.
- Lupin launches Clobetasol Propionate Lotion.
- Lupin launches ADHD treatment tablets in the US.
- Lupin launches generic influenza treatment capsules in the US.
2019
- Lupin receives US FDA approval for hypothyroidism treatment drug.
- Lupin launches generic antidepressant drug in the US.
- Lupin receives US FDA approval for generic Tadalafil tablets.
- Lupin launches seizures drug in the US.
- Lupin launches Minocycline Hydrochloride tablets in the US.
2020
- Lupin's Pithampur facilities pass MHRA inspection.
- Lupin launches generic arthritis relief tablet in the US.
- Lupin receives EIR from US FDA for Florida inhalation research centre.
- Lupin receives EIR from US FDA for Nagpur plant.
- Lupin receives US FDA approval for generic product.
2021
- Lupin receives US FDA approval for generic anti-fungal cream.
- LupinLife launches ayurvedic energy supplement Be One.
- Lupin launches Posaconazole delayed-release tablets.
- Lupin launches generic Wilson's disease drug in the US.
- Lupin launches generic diarrhea drug in the US.
2022
- Lupin receives US FDA approval for Efinaconazole Topical Solution.
- Lupin launches first reference laboratory in Kolkata.
- Lupin receives US FDA approval for Vigabatrin for Oral Solution USP.
- Lupin completes acquisition of brands from Anglo-French.
- Lupin launches Merzee Capsules in the US.
2023
- Lupin launches Softovac Liqui fibre liquid fibre product.
- Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the US.
- Lupin launches Rocuronium Bromide Injection in the US.
- Lupin launches Diazepam Rectal Gel in the US.
- Lupin agrees to acquire 5 drug brands from Menarini for Rs 101 crore.
2024
- Lupin and Slurrp conclude Lupin Aptivate Achchi Bhookh Quiz.
- Lupin acquires Huminsulin from Lilly to enhance diabetes portfolio.
- Lupin receives US FDA approval for Emtricitabine and Tenofovir Alafenamide Tablets.
- Lupin acquires 3 trademarks from Boehringer Ingelheim to strengthen diabetes portfolio.
- Lupin's Pune R&D facility awarded LEED Platinum Certification.
- Lupin launches Bumetanide Injection USP in the United States.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800